JHP Pharmaceuticals sterile manufacturing site based in Rochester, MI successfully completed a GMP/Pre-Approval Audit by the FDA. This audit followed two successful GMP audits in 2009 including an audit by the FDA biologics division (CBER) and an audit by the European Medicines Agency (EMEA), which resulted in a continuance of the certificate of GMP compliance for the manufacturing site. Stuart Hinchen, co-founder and president of JHP, said, “We are extremely pleased with the results of...